Global Genome Editing/Genome Engineering Market: Overview

Genome editing/genome engineering refers to the techniques and strategies in which the DNA is deleted, replaced or inserted in the living organism’s genome with the help of molecular scissors or engineered nucleases. It is one of the active fields of research owing to its wide array of potential applications, specifically related to human health such as the manufacturing of therapeutic proteins, the rectification of a gene with a detrimental mutation, and the removal of repeated viral sequences. It also has an application in agricultural biotechnology such as the invention of novel generations of genetically modified plants. Genome editing/genome engineering can also be used in the improvement of research tools, for instance, to exploit a gene’s function of a gene.

Request Free Sample Report @

Global Genome Editing/Genome Engineering Market: Growth Factors

The in general increase in the manufacturing of genetically modified crops, the fast rise in the figure of biotechnology and pharmaceutical companies, the growing government expenditure for genomics, increasing R&D activities in the life science research, raised need of synthetic genes, and technological enhancements are few factors propelling the growth of the genome editing/genome engineering market. However, the strict regulatory authorities and ethical concerns are few factors impeding the market growth.

Global Genome Editing/Genome Engineering Market: Segmentation

The global genome editing/genome engineering market can be segmented based on application, technology, end-user, and region. The application segment of the market is diversified into plant genetic engineering, cell line engineering, animal genetic engineering, and other applications. The technology segment of the market is categorized into antisense, CRISPR, ZFN, TALEN, and other technologies. The end-user segment of the genome editing/genome engineering market is grouped into contract research organizations, academic & government research institutes, biotechnology & pharmaceutical companies, and other applications. Regionally, the market is sub-segmented into Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa.

Global Genome Editing/Genome Engineering Market: Regional Analysis

North America is expected to dominate the market for genome editing/genome engineering owing to various factors, including the rising utilization of genetically modified crops; occurrence of dementia, Alzheimer’s disease, infectious diseases, and cancer in this region; the development of gene therapy; standard conferences and workshops for genome editing; and the rising accessibility of research funding and grants. Asia Pacific region is also anticipated to grow at a fast pace in the market in the coming period. The growth of this region can be mainly attributed to the amplified R&D expenditure and the development of foremost genome editing industries.

Global Genome Editing/Genome Engineering Market: Competitive Players

The major players in the genome editing/genome engineering market are Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc., Horizon Discovery Group Plc., and Lonza Group Ltd. The other major players in the market include Sangamo Biosciences, Inc., New England Biolabs, Inc., Merck KGAA, Origene Technologies, Inc., and Transposagen Biopharmaceuticals, Inc.